Page 51 - Micro5 Brochure 2017
P. 51
RESULTS:
For each trial, n = 31. In trial 1, 50 μA was more effective than 500 μA, with 93% of participants
'much better' or 'fully recovered' at 15 weeks, compared with 47% in the 500 μA group. Tendon
structural normalization was superior at 50 μA, but no significant differences were found in other
outcomes. In trial 2, success rates for the two groups at 15 weeks were 75% and 73%,
respectively, but group improvements did not differ significantly on any measure. Pooled
analysis of data from both trials showed that, immediately following treatment, blood flow had
fallen in the subgroup with high baseline scores and risen in the subgroup with low scores. Low
baseline score correlated significantly with treatment success.
CONCLUSION:
Monophasic MCT of peak current intensity 50 μA applied for tens of hours may be effective in
reducing symptoms and promoting tendon normalization in chronic tennis elbow. Hyperaemia
may help predict treatment outcome. A full-scale trial of the therapy is warranted.
Copyright © 2011 John Wiley & Sons, Ltd.
PMID:
22147671
[PubMed - indexed for MEDLINE]
Disabil Rehabil. 2004 Jun 3;26(11):669-77.
Does microcurrent stimulation increase the range of movement of
ankle dorsiflexion in children with cerebral palsy?
Mäenpää H, Jaakkola R, Sandström M, Von Wendt L.
Author information
Abstract
AIM:
To determine whether microcurrent stimulation (MENS) increases the range of motion (ROM) of
the ankle joint in children with cerebral palsy.
